Antithrombogenic activity of antioxidant compounds

Bulletin of Experimental Biology and Medicine

Volumn 155, Issue 6, 2013, Pages 775-777

  Spasov, A A ^a   Kucheryavenko, A F ^a   Kosolapov, V A ^a   Anisimova, V A ^b  

^a VOLGOGRAD STATE MEDICAL UNIVERSITY   (Russian Federation)

^b SOUTHERN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

antioxidant activity; antithrombotic effect; platelet aggregation; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIOXIDANT; ENOXIFOL; FERRIC CHLORIDE; FIBRINOLYTIC AGENT; MEXIDOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ANTIOXIDANT ACTIVITY; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; FIBRINOLYSIS; IN VITRO STUDY; IN VIVO STUDY; MALE; MEDIAN EFFECTIVE CONCENTRATION; NONHUMAN; PHARMACOLOGICAL PARAMETERS; RAT; THROMBOCYTE AGGREGATION;

RATTUS;

ANIMALS; ANIMALS, OUTBRED STRAINS; ANTICOAGULANTS; ANTIOXIDANTS; ASPIRIN; BENZIMIDAZOLES; CAROTID ARTERY THROMBOSIS; DRUG EVALUATION, PRECLINICAL; MALE; PICOLINES; PLATELET AGGREGATION; RATS;

EID: 84888301185     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-013-2250-x     Document Type: Article

References (13)

1. V. A. Anisimova, A. A. Spasov, V. A. Kosolapov, et al., Khim. Farm. Zh., 43, No. 9, 9-12 (2009).
2. I. P. Danilov, Med. Novosti, No. 9, 17-20 (2008).
3. V. A. Kosolapov, A. A. Spasov, and V. A. Anisimova, Biomed. Khim., 51, No. 3, 287-294 (2005).
4. V. V. Nikonov and E. I. Kinoshenko, Meditsina Neotlozhn. Sost., No. 3, 109-119 (2008).
5. V. A. Anisimova, V. A. Kosolapov, A. A. Spasov, et al., Patent of RF No. 2391979. Dihydro 9-(3,4-dihydroxyphenyl)-9-diethylaminoethylimidazo[1,2-a] benzimidazole and pharmaceutical composition based on it, Byull. Otkryt., No. 17 (2010).
6. V. I. Petrov, N. V. Rogova, and D. O. Mikhailova, Vestn. Vol. Gos. Med. Univer., 33, No. 1, 28-32 (2010).
7. A. A. Spasov, O. V. Ostrovskii, I. V. Ivakhnenko, et al., Eksp. Klin. Farmakol., 62, No. 1, 38-40 (1999).
8. I. N. Tyurenkov and A. V. Voronkov, Eksp. Klin. Farmakol., 71, No. 1, 49-51 (2008).
9. J. M. Dogne, J. Hanson, X. de Leval, et al., J. Pharmacol. Exp. Ther., 309, No. 2, 498-505 (2004).
10. J. E. Freedman, Arterioscler. Thromb. Vasc. Biol., 28, No. 3, s11-s16 (2008).
11. I. Hagedorn, T. Vogtle, and B. Nieswandt, Hemostaseologie, 30, No. 3, 127-135 (2010).
12. K. D. Kurz, B. W. Main, and G. E. Sandusky, Thromb. Res., 60, No. 4, 269-280 (1990).
13. R. J. Westrick, M. E. Winn, and D. T. Eitzman, Arterioscler. Thromb. Vasc. Biol., 27, No. 10, 2079-2093 (2007).